发明名称 |
formulações galênicas de compostos orgânicos |
摘要 |
The invention provides a pharmaceutical oral fixed dose combination of aliskiren and valsartan. Aliskiren is shown to slow the dissolution rate of valsartan and the resultant undesirable gelling of valsartan in the presence of aliskiren is overcome by the use of disintegrants. |
申请公布号 |
BRPI1009468(A2) |
申请公布日期 |
2016.03.01 |
申请号 |
BR2010PI09468 |
申请日期 |
2010.03.18 |
申请人 |
NOVARTIS AG |
发明人 |
HONG WEN;INDRAJIT GHOSH;SHOUFENG LI;SUDHA VIPPAGUNTA;WEI-QIN TONG |
分类号 |
A61K9/00;A61K9/20 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|